July 2nd, 2021
Listed below is a message sent by my late daughter Shayna two years ago (July 2, 2019) to promote Sarcoma Awareness Month.
Yesterday was the first day of Sarcoma Awareness Month. As someone that is currently fighting a sarcoma I can say that my…
Read ArticleJune 27th, 2021
Published: Jun 21, 2021
SAN DIEGO, June 21, 2021 /PRNewswire/ — InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109…
Read ArticleJune 19th, 2021
SUMMARY
This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in treating patients with conventional chondrosarcoma that cannot be removed by surgery (unresectable) and has spread to other places in…
Read ArticleJune 3rd, 2021
Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health.
The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer Center (mskcc.org)
Transcript:
Barbra Rothschild:…
Read ArticleMay 26th, 2021
Targeted Cancer Therapies
ON THIS PAGE
What are targeted cancer therapies?
How are targets for targeted cancer therapies identified?
How are targeted therapies developed?
What types of targeted therapies are available?
…
Read ArticleMay 25th, 2021
Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript.
The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer…
Read ArticleMay 16th, 2021
SAN DIEGO, Nov. 11, 2020 /PRNewswire/ –InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced updated interim results today from a Phase 1 clinical trial evaluating the efficacy and safety of…
Read ArticleMay 8th, 2021
This coming Friday will be the Chondrosarcoma Foundation’s first anniversary. Last year, on May 14, 2020 during the beginning of the pandemic, we launched the Chondrosarcoma Foundation by bringing CS Foundation web site on-line. My…
Read ArticleMay 7th, 2021
November 13, 2020
Dylann Cohn-Emery
Treatment with the investigation agent INBRX-109 induced responses and decreased the tumor burden in a cohort of patients with chondrosarcoma, according to interim efficacy and safety findings a phase 1 trial in…
Read ArticleInhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year
Read Article